Aurobindo Pharma Ltd. (AUROPHARMA)
Market Closed
10 Aug, 22:00
MSE XNSE Primary MSE ₹
1,646. 00
-15
-0.9031%
₹
- Market Cap
- P/E Ratio
6% Div Yield
49,631 Volume
- Eps
₹ 1,661
Previous Close Want to track AUROPHARMA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Aurobindo Pharma Ltd. (AUROPHARMA) Statistics
Valuation metrics
Market Cap -
Enterprise value 936B
Trailing P/E (ttm) 27.48
Forward P/E -
PEG ratio 31.01
Price/Sales (ttm) 2.83
Price/Book (mrq) 2.54
Enterprise Value/Revenue 2.78
Enterprise Value/EBITDA 13.05
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 85.66K
Average volume (90 days) 53.53K
Price summary
52-Week low 1,017
52-Week high 1,671.3
Beta -
50-Day moving average 1,563.33
200-Day moving average 1,387
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 4
Trailing annual dividend yield 0.0024%
5-Year annual dividend yield -
Payout ratio 0.07
Dividend Date 21 Aug 2025
Ex-Dividend Date 8 Aug 2025
Last split factor 2:1
Last split Date 20 Jul 2015
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.1%
Operating margin 0.22%
Operational effectiveness
Return on assets 0.06%
Return on equity 0.1%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 579.36
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 60.34
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 182.79
Total debt (mrq) -
Total Debt/Equity (mrq) 0.21
Current ratio (mrq) 1.81%
Book value per share (mrq) 652.17
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
